Bioimpedance Body Composition

For physicians

What is measured

Multi-frequency bioelectrical impedance analysis producing fat mass, lean body mass, soft lean mass, skeletal muscle mass, intracellular and extracellular water, and segmental distribution. Body mass index is retained for reporting compatibility and is treated as insufficient on its own for characterizing an individual’s health status or body composition.

Why it is a required denominator, not an optional extra

Resting energy expenditure is produced overwhelmingly by lean tissue. An absolute value from indirect calorimetry is therefore uninterpretable without a concurrent lean mass figure — a low measured expenditure in a sarcopenic patient is an expected finding about muscle, not a finding about metabolism.

The same applies to metabolic risk. Sarcopenic patients at normal body mass index carry a risk profile that neither weight nor body mass index reveals, and segmental distribution identifies lower-limb muscle loss, which bears directly on balance and on glucose disposal.

Sources of variance to control

• Hydration status — the dominant confounder. Standardize fasting and fluid intake.
• Recent exercise, recent meal, bladder fullness, ambient temperature.
• Menstrual cycle phase, where relevant.
• Electrode contact — dry, callused or lotioned skin degrades the measurement.
• Contraindicated with implanted electrical devices.

Where it fits

Acquired first in the sequence, because it takes minutes and because everything metabolic is read against it. Interpreting the report.

Evidence and limitations

Written for a reader who wants the literature rather than the summary. Where the evidence is thin we say so and give both sides, and where a claim is mechanistic rather than demonstrated we label it as such.

Mechanism

Lean tissue is largely water and electrolyte and conducts an applied alternating current well; adipose tissue conducts poorly. Measuring impedance at multiple frequencies allows total body water to be estimated and partitioned between intracellular and extracellular compartments, from which soft lean mass, lean body mass and fat mass follow. Because hydration is the dominant determinant of the signal, standardized conditions are not a refinement — they are the measurement.

What the evidence shows

The clinical case for measuring composition rather than weight rests on the fact that body mass index misclassifies a specific and common phenotype. Analysis of 6,171 adults over 20 in the Third National Health and Nutrition Examination Survey whose body mass index was in the normal range (18.5–24.9 kg/m²), with body composition assessed and mortality follow-up available for more than 99% over a median 8.8 years, defined normal weight obesity as the highest sex-specific tertile of body fat — above 23.1% in men and 33.3% in women.

In that group the prevalence of metabolic syndrome was four times higher than in the low body fat group (16.6% versus 4.8%, p < 0.0001), with higher prevalence of dyslipidemia, hypertension in men and cardiovascular disease in women. After adjustment, women with normal weight obesity had a 2.2-fold increased risk of cardiovascular mortality (hazard ratio 2.2, 95% CI 1.03 to 4.67) compared with the low body fat group.

Separately, the metabolic health data this site quotes throughout shows the same point from the other direction: in the 2009–2016 survey, fewer than one in three normal-weight American adults met a full definition of optimal metabolic health.

Limitations of that evidence

• The normal weight obesity study used a different body composition method. Its conclusions are about the phenotype, not a validation of any particular impedance device.
• Hydration, recent meals, exercise and bladder fullness all move an impedance reading, which is why it is reproducible under standardized conditions and unreliable without them.
• Tertile-based definitions are arbitrary. The 23.1% and 33.3% thresholds are properties of that survey sample, not universal cut points.
• Observational design and wide confidence intervals. The mortality hazard ratio’s lower bound is 1.03; the finding is significant and it is not precise.
• Contraindicated with implanted electrical devices, so the measurement is not available in part of the population most likely to benefit from characterization.

What remains uncertain

Whether acting on a body composition measurement — as distinct from acting on weight, waist and metabolic markers — changes outcomes has not been tested. The defensible claims are narrower and still useful: composition identifies a phenotype that body mass index hides and that carries measurably worse metabolic and, in women, mortality risk; and lean mass is the denominator without which a measured resting energy expenditure cannot be interpreted at all.